Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: Association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 57-62

  John, Grace C ^a   Nduati, Ruth W ^b   Mbori Ngacha, Dorothy ^b   Overbaugh, Julie ^b   Welch, Mary ^b   Richardson, Barbra A ^b   Ndinya Achola, Jeckoniah ^b   Bwayo, Job ^b   Krieger, John ^b   Onyango, Francis ^b   Kreiss, Joan K ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL FREE SYSTEM; DISEASE ASSOCIATION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RETINOL DEFICIENCY; SEROCONVERSION; VAGINA DISCHARGE; VERTICAL TRANSMISSION; VIREMIA; VIRUS SHEDDING;

EID: 16944365376     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.57     Document Type: Article

References (22)

1. WHO/GPA/CNP/EVA/93.1. Global program on AIDS. Geneva: WHO, 1993.
2. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:253-65.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
4. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 1994;271:1925-30.
5. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
6. 2-microglobulin, HIV-1 p24 antibody and acid dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant women. AIDS 1993;7:1475-9.
7. Khouri YF, McIntosh K, Cavacini L, et al. Vertical transmission of HIV-1: correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest 1995;95:732-7.
8. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic and placental factors. JAMA 1993;269:2853-9.
9. Vogt MW, Witt DJ, Craven DE, et al. Isolation patterns of human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:380-2.
10. Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986;1:527-9.
11. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170:1597-601.
12. Clemetson DBA, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. JAMA 1993;269:2860-4.
13. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syn 1993; 6:72-5.
14. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 1992;267:2769-74.
15. Mermin JH, Holodniy M, Katzenstein DA, et al. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991;164:769-72.
16. Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 1995;172:1461-8.
17. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343: 1593-7.
18. Riley DE, Roberts MC, Takayama T, Kreiger JN. Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J Clin Microbiol 1992;30:465-72.
19. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 depletion. J Infect Dis 1995;172:1469-75.
20. Cameron BW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency type 1: risk factors for seroconversion in men. Lancet 1989;2:403-8.
21. Laga M, Manoka AT, Kivuvu M, et al. Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
22. Nair P, Alger L, Hines S, et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr 1993;6:298-302.